Acrivon Therapeutics
ACRV
#9611
Rank
โ‚น3.64 B
Marketcap
โ‚น116.40
Share price
-2.88%
Change (1 day)
-76.36%
Change (1 year)

Acrivon Therapeutics (ACRV) - Cash on Hand

Cash on Hand as of December 2024 : โ‚น15.47 Billion

According to Acrivon Therapeutics's latest financial reports the company has โ‚น15.47 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Acrivon Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น10.61 B0.37%
2022-12-31โ‚น10.57 B42.6%
2021-12-31โ‚น7.41 B6303.64%
2020-12-31โ‚น0.11 B